Compounds > 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan
Page last updated: 2024-09-03

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and Carcinoma, Anaplastic

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coveñas, R; Muñoz, M; Rosso, M1

Other Studies

1 other study(ies) available for 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and Carcinoma, Anaplastic

ArticleYear
The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Survival; Gastrointestinal Neoplasms; Humans; Neurokinin-1 Receptor Antagonists; Tryptophan

2017